215 related articles for article (PubMed ID: 31300476)
1. A New Switch for TGFβ in Cancer.
Yeh HW; Lee SS; Chang CY; Lang YD; Jou YS
Cancer Res; 2019 Aug; 79(15):3797-3805. PubMed ID: 31300476
[TBL] [Abstract][Full Text] [Related]
2. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy.
Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X
Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538
[TBL] [Abstract][Full Text] [Related]
3. TGFbeta and cancer metastasis: an inflammation link.
Yang L
Cancer Metastasis Rev; 2010 Jun; 29(2):263-71. PubMed ID: 20437081
[TBL] [Abstract][Full Text] [Related]
4. PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.
Yeh HW; Hsu EC; Lee SS; Lang YD; Lin YC; Chang CY; Lee SY; Gu DL; Shih JH; Ho CM; Chen CF; Chen CT; Tu PH; Cheng CF; Chen RH; Yang RB; Jou YS
Nat Cell Biol; 2018 Apr; 20(4):479-491. PubMed ID: 29593326
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta signalling: a complex web in cancer progression.
Ikushima H; Miyazono K
Nat Rev Cancer; 2010 Jun; 10(6):415-24. PubMed ID: 20495575
[TBL] [Abstract][Full Text] [Related]
6. Krüppel-like Transcription Factor KLF10 Suppresses TGFβ-Induced Epithelial-to-Mesenchymal Transition via a Negative Feedback Mechanism.
Mishra VK; Subramaniam M; Kari V; Pitel KS; Baumgart SJ; Naylor RM; Nagarajan S; Wegwitz F; Ellenrieder V; Hawse JR; Johnsen SA
Cancer Res; 2017 May; 77(9):2387-2400. PubMed ID: 28249899
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
8. TGFbeta-regulated transcriptional mechanisms in cancer.
Ellenrieder V; Buck A; Gress TM
Int J Gastrointest Cancer; 2002; 31(1-3):61-9. PubMed ID: 12622416
[TBL] [Abstract][Full Text] [Related]
9. Switching TGFβ from a tumor suppressor to a tumor promoter.
Inman GJ
Curr Opin Genet Dev; 2011 Feb; 21(1):93-9. PubMed ID: 21251810
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2.
Xu J; Acharya S; Sahin O; Zhang Q; Saito Y; Yao J; Wang H; Li P; Zhang L; Lowery FJ; Kuo WL; Xiao Y; Ensor J; Sahin AA; Zhang XH; Hung MC; Zhang JD; Yu D
Cancer Cell; 2015 Feb; 27(2):177-92. PubMed ID: 25670079
[TBL] [Abstract][Full Text] [Related]
12. PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression.
Lang YD; Jou YS
J Biomed Sci; 2021 Aug; 28(1):57. PubMed ID: 34340703
[TBL] [Abstract][Full Text] [Related]
13. Abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Lin X; Feng XH
World J Surg; 2005 Mar; 29(3):312-6. PubMed ID: 15706432
[TBL] [Abstract][Full Text] [Related]
14. Targeting TGFβ signal transduction for cancer therapy.
Liu S; Ren J; Ten Dijke P
Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
[TBL] [Abstract][Full Text] [Related]
16. Regulation of EMT by TGFβ in cancer.
Heldin CH; Vanlandewijck M; Moustakas A
FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
[TBL] [Abstract][Full Text] [Related]
17. Role of TGFbeta signaling in skin carcinogenesis.
Wang XJ
Microsc Res Tech; 2001 Feb; 52(4):420-9. PubMed ID: 11170301
[TBL] [Abstract][Full Text] [Related]
18. Context-dependent action of transforming growth factor β family members on normal and cancer stem cells.
Caja L; Kahata K; Moustakas A
Curr Pharm Des; 2012; 18(27):4072-86. PubMed ID: 22630079
[TBL] [Abstract][Full Text] [Related]
19. The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.
Wang T; Wang D; Zhang L; Yang P; Wang J; Liu Q; Yan F; Lin F
J Exp Clin Cancer Res; 2019 May; 38(1):226. PubMed ID: 31138318
[TBL] [Abstract][Full Text] [Related]
20. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
